OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…
Mary-Claire King received Lasker Foundation Award
On Sept. 8, 2014, the University of Washington and UW Medicine announced that Mary-Claire King, UW professor of…
Amgen announced closure of Seattle and Bothell facilities
On Jul. 29, 2014, Amgen announced the closure of facilities in Seattle and Bothell which resulted in the…
Omeros received FDA Approval of Omidriaï¾™
On Jun. 2, 2014, Omeros received FDA approval of Omidriaï¾™ for use in cataract and other intraocular lens…
Bezos family donated $20 million to the Fred Hutch to develop therapies that ‘melt’ cancer
On Apr. 7, 2014, the Fred Hutchinson Cancer Research Center announced that the Bezos family had committed $20…
Neanderthal genes unearthed in modern humans
On Jan. 29, 2014, Neanderthal genes were unearthed in modern humans by University of Washington scientists Benjamin Vernot…
InBios received USDA license for its West Nile Virus antibody detection kit for horses
On Jan. 24, 2014, InBios announced that it had licensed a U.S. Department of Agriculture (USDA) West Nile…
Benaroya Research Institute received 7-year award to lead Immune Tolerance Network
On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason…
Juno Theraputics was founded
On Dec. 3, 2013, Juno Theraputics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, was…
The Roux Prize was established
On Nov. 9, 2013, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington launched…
Pacific Northwest Diabetes Research Institute received a $2 million grant for RNA research
On Aug. 6, 2013, Pacific Northwest Diabetes Research Institute (PNDRI) received a $2 million National Institutes of Health…
Matrical Bioscience acquired by Brooks Automation for $10 million
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
NanoString Technologies completed its IPO
On Jun. 25, 2013, NanoString Technologies launched an initial public offering at $10.00 per share and raised $54…
Syntrix Biosystems won $115 million judgment in patent case against Illumina, the largest patent verdict in Washington state history
On Jun. 20, 2013 – Syntrix Biosystems announced a federal court in Tacoma, had granted the Auburn-based company…
Biotechnology | Genomics | Life Science History | Life Science News | Non-Profit Research | Prehistory
DNA analysis unearthed origins of Minoans, the first major European civilization
On May 14, 2013, a University of Washington led team announced tht DNA analysis had unearthed the origins…
Genome of the coelacanth sequenced
On Apr. 17, 2013, researchers from the University of Washington, Broad Institute of Harvard and M.I.T. announced that…
Mountain pine beetle genome was decoded
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre…
Atossa Genetics completed its IPO
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
The NIH awarded $65 million grant to Institute for Translational Health Sciences to turn promising discoveries into patient care advances
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
Washington State Secretary of Health declared a pertussis epidemic
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By Jun. 16, the…
University of Washington Medical Center becomes first in PNW to discharge Total Artificial Heart patient
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
Amnis Corp. was acquired by EMD Millipore
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…
The FDA approved Seattle Genetics’ Adcetris (brentuximab vedotin)
On Aug. 19, 2011, the FDA approved Seattle Genetics’ Adcetris (brentuximab vedotin), making it the first drug for…
Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from Madigan Army Medical
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
Cardiac Science acquired by Opto Circuits of India for $55 million
On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….
Trubion Pharmaceutical was acquired by Emergent BioSolutions
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
HaloSource completed its IPO
On Oct. 12, 2010, HaloSource completed its IPO on the London Stock Exchange and raised $50 million in…